Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cardiovascular Research

• Publication date

  2004-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CARDIORES.2004.07.022PMID 15537499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes

  2004cited by this paper
• Molecular Basis for Kv1.5 Channel Block

  2004cited by this paper
• Effects of Irbesartan on Cloned Potassium Channels Involved in Human Cardiac Repolarization

  2003cited by this paper
• Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines

  2003cited by this paper
• Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).

  2002cited by this paper
• Genetic Manipulation of Cardiac K+ Channel Function in Mice: What Have We Learned, and Where Do We Go From Here?

  2001cited by this paper
• Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.

  2001cited by this paper
• Regulation of KChIP2 potassium channel β subunit gene expression underlies the gradient of transient outward current in canine and human ventricle

  2001cited by this paper
• Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.

  2001cited by this paper
• Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs.

  2001cited by this paper
• hKv4.3 channel characterization and regulation by calcium channel antagonists.

  2001cited by this paper
• Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes

  2000cited by this paper
• Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K+ Currents

  2000cited by this paper
• Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.

  2000cited by this paper
• Effects of a quaternary bupivacaine derivative on delayed rectifier K+ currents

  2000cited by this paper
• Calcium-antagonist drugs.

  1999cited by this paper
• Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.

  1999cited by this paper
• Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model.

  1998cited by this paper
• Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5.

  1997cited by this paper
• Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current.

  1996cited by this paper
• Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.

  1994cited by this paper
• Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.

  1993cited by this paper
• Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.

  1993cited by this paper
• Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes.

  1991cited by this paper
• Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

  1990cited by this paper
• Characteristics of the time-dependent slow inward current in adult human atrial single myocytes.

  1986cited by this paper

• Inhibition of Cardiac Kv4.3/KChIP2 Channels by Sulfonylurea Drug Gliquidone

  2023cites this paper
• Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept

  2021cites this paper
• Differential suppression of delayed-rectifier and inwardly rectifier K+ currents by a group of ent-kaurane-type diterpenoids from Croton tonkinensis, in microglial cells.

  2019cites this paper
• Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5

  2019cites this paper
• High Effectiveness in Actions of Carfilzomib on Delayed-Rectifier K+ Current and on Spontaneous Action Potentials

  2019cites this paper
• Coupling of excitation to Ca2+ release is modulated by dysferlin

  2017cites this paper
• Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation

  2016cites this paper
• Patch-Clamp and Voltage-Clamp Techniques

  2015cites this paper
• Protective effects of diltiazem against vascular endothelial cell injury induced by angiotensin‐II and hypoxia

  2015cites this paper
• Intravenous Anesthetic Propofol Inhibits Multiple Human Cardiac Potassium Channels

  2015cites this paper
• Pharmacology of Voltage-Gated Calcium Channels in Clinic

  2014cites this paper
• The potential role of Kv4.3 K+ channel in heart hypertrophy

  2014cites this paper
• Effects of L-type Calcium Channel Antagonists Verapamil and Diltiazem on fKv1.4ΔN Currents in Xenopus oocytes

  2013cites this paper
• Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action

  2013cites this paper
• Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes

  2012cites this paper
• Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.

  2012cites this paper
• Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes

  2011cites this paper
• ILLUSTRATION OF TRANSMEMBRANE RESTING OR DIASTOLIC POTENTIAL IN A CARDIAC CELL AND MEASUREMENT WITH GALVANOMETER

  2010cites this paper
• Open channel block of the fast transient outward K+ current by primaquine and chloroquine in rat left ventricular cardiomyocytes.

  2010cites this paper
• IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

  2009cites this paper
• I Kur /Kv1.5channelblockersforthe treatmentofatrialfibrillation

  2009cites this paper
• I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.

  2009cites this paper
• Effects of MiRP1 and DPP6 β‐subunits on the blockade induced by flecainide of KV4.3/KChIP2 channels

  2008cites this paper
• Functional parameters of voltage-activated Ca2+ currents from olfactory interneurons in the antennal lobe of Periplaneta americana.

  2008cites this paper
• Characterization of Human Cardiac Kv1.5 Inhibition by the Novel Atrial-selective Antiarrhythmic Compound AVE1231

  2008cites this paper
• RESEARCH PAPER Effects of MiRP1 and DPP6 b-subunits on the blockade induced by flecainide of K V 4.3/KChIP2 channels

  2008cites this paper
• A new hypothesis for Ca2+ flows in skeletal muscle and its implications for other cell types

  2006cites this paper
• Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1+minK channels

  2005cites this paper
• MOLPHARM-AR-2023-000787R Inhibition of cardiac Kv4.3/KChIP2 channels by a sulfonylurea drug gliquidone

  year unknowncites this paper